• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Randomized Study Comparing a Novel Intranasal Formulation of Bumetanide With Oral and Intravenous Formulations.

作者信息

Ambrosy Andrew P, Bensimhon Daniel, Bernstein Galina, Kolski Brian, Neutel Joel, Lala Anuradha, Kapur Navin K, Esque Benjamin, Adler Eric

机构信息

Kaiser Permanente San Francisco Medical Center, CA (A.P.A.).

Kaiser Permanente Northern California Division of Research, Pleasanton (A.P.A.).

出版信息

Circulation. 2025 Mar 11;151(10):737-740. doi: 10.1161/CIRCULATIONAHA.124.072949. Epub 2024 Nov 18.

DOI:10.1161/CIRCULATIONAHA.124.072949
PMID:39555978
Abstract
摘要

相似文献

1
Randomized Study Comparing a Novel Intranasal Formulation of Bumetanide With Oral and Intravenous Formulations.比较布美他尼新型鼻内制剂与口服和静脉制剂的随机研究。
Circulation. 2025 Mar 11;151(10):737-740. doi: 10.1161/CIRCULATIONAHA.124.072949. Epub 2024 Nov 18.
2
Correction to: Randomized Study Comparing a Novel Intranasal Formulation of Bumetanide to Oral and Intravenous Formulations.
Circulation. 2025 Mar 11;151(10):e708. doi: 10.1161/CIR.0000000000001317. Epub 2025 Mar 10.
3
Formulation of nasal analgesic sprays with diclofenac sodium, ibuprofen, paracetamol, and evaluation of toxicity.双氯芬酸钠、布洛芬、对乙酰氨基酚鼻腔镇痛喷雾剂的配方及毒性评估。
Sci Prog. 2024 Oct-Dec;107(4):368504241304200. doi: 10.1177/00368504241304200.
4
Inhibition of Na-K-Cl cotransporter isoform 1 reduces lung injury induced by ischemia-reperfusion.抑制钠-钾-氯协同转运蛋白 1 亚型可减轻缺血再灌注引起的肺损伤。
J Thorac Cardiovasc Surg. 2017 Jan;153(1):206-215. doi: 10.1016/j.jtcvs.2016.09.068. Epub 2016 Oct 24.
5
A study of the pharmacodynamic differences between immediate and extended release bumetanide formulations.
Int J Pharm. 2003 Nov 28;267(1-2):129-40. doi: 10.1016/j.ijpharm.2003.08.007.
6
Bumetanide to Treat Parkinson Disease: A Report of 4 Cases.布美他尼治疗帕金森病：4例报告
Clin Neuropharmacol. 2016 Jan-Feb;39(1):57-9. doi: 10.1097/WNF.0000000000000114.
7
Electrolyte excretion patterns. Intravenous and oral doses of bumetanide compared to furosemide.
J Clin Pharmacol. 1981 Nov-Dec;21(11):599-603. doi: 10.1002/j.1552-4604.1981.tb05670.x.
8
Clarifications regarding bumetanide for neonatal seizures.关于布美他尼治疗新生儿癫痫的澄清。
Epilepsia. 2022 Jul;63(7):1863-1867. doi: 10.1111/epi.17278. Epub 2022 May 26.
9
Comparison of Urine Output Response of Intravenous Bumetanide and Furosemide in Acute Decompensated Heart Failure: An Observational Analysis.急性失代偿性心力衰竭中静脉注射布美他尼和呋塞米的尿量反应比较：一项观察性分析
J Cardiovasc Pharmacol. 2025 Mar 1;85(3):233-237. doi: 10.1097/FJC.0000000000001658.
10
Intranasal administration of different liquid formulations of bumetanide to rabbits.
Int J Pharm. 2000 Aug 25;204(1-2):35-41. doi: 10.1016/s0378-5173(00)00461-0.

引用本文的文献

1
Cardiovascular inhalation for targeted drug delivery in cardiac disease.用于心脏病靶向药物递送的心血管吸入法。
Heart Fail Rev. 2025 May 23. doi: 10.1007/s10741-025-10527-w.
2
Bumetanide nasal spray: a novel approach to enhancing diuretic response and advancing ambulatory heart failure care?布美他尼鼻喷雾剂：增强利尿反应及推进门诊心力衰竭护理的新方法？
Heart Fail Rev. 2025 May 13. doi: 10.1007/s10741-025-10517-y.